NDC 51672-4040-01 - Enalapril Maleate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51672-4040
- Requested NDC
- 51672-4040-01
- Package NDCs from labels
- 51672-4040-1, 51672-4040-3, 51672-4040-01
- Manufacturer
- Bryant Ranch Prepack
- Effective date
- 2026-08-11
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Enalapril Maleate - Bryant Ranch Prepack | Bryant Ranch Prepack | 2026-08-11 | HUMAN PRESCRIPTION DRUG LABEL |
| Enalapril Maleate Tablets, USP | Golden State Medical Supply, Inc. | 2026-08-05 | HUMAN PRESCRIPTION DRUG LABEL |
| Enalapril Maleate Tablets, USP | Sun Pharmaceutical Industries, Inc. | Taro Pharmaceuticals Industries Ltd. | 2026-07-14 | HUMAN PRESCRIPTION DRUG LABEL |
| Enalapril Maleate - A-S Medication Solutions | A-S Medication Solutions | 2026-01-06 | HUMAN PRESCRIPTION DRUG LABEL |
| Enalapril Maleate - Northwind Health Company, LLC | Northwind Health Company, LLC | 2026-01-01 | HUMAN PRESCRIPTION DRUG LABEL |
| Enalapril Maleate - Bryant Ranch Prepack | Bryant Ranch Prepack | 2024-04-03 | HUMAN PRESCRIPTION DRUG LABEL |
| Enalapril Maleate Tablets, USP | REMEDYREPACK INC. | 2024-01-03 | HUMAN PRESCRIPTION DRUG LABEL |
| Enalapril Maleate - Denton Pharma, Inc. DBA Northwind Pharmaceuticals | Denton Pharma, Inc. DBA Northwind Pharmaceuticals | 2023-01-01 | HUMAN PRESCRIPTION DRUG LABEL |
| Enalapril Maleate - Denton Pharma, Inc. dba Northwind Pharmaceuticals | Denton Pharma, Inc. dba Northwind Pharmaceuticals | 2020-07-08 | HUMAN PRESCRIPTION DRUG LABEL |
| Enalapril Maleate - Proficient Rx LP | Proficient Rx LP | 2020-03-01 | HUMAN PRESCRIPTION DRUG LABEL |
| Enalapril Maleate Tablets, USP | Blenheim Pharmacal, Inc. | 2015-02-19 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51672-4040-1 | Enalapril Maleate | 100 in 1 BOTTLE | TABLET | 100 | 13 | |
| 51672-4040-3 | Enalapril Maleate | 1000 in 1 BOTTLE | TABLET | 1000 | 13 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51672-4040 | ENALAPRIL MALEATE TABLET [TARO PHARMACEUTICALS U.S.A., INC.] | 13 | Current NDC, Legacy NDC, 2 package rows | 20230728_f103b9f9-e081-419d-a2d8-b86acda834dd.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 51672-4040-1 | EA - Each | 51672-4040 | 4dcf6987-7ffe-465e-b63f-328049319742 | 1 | 2013-02-13 |
| 51672-4040-3 | EA - Each | 51672-4040 | 0657f60b-0138-4b94-87cc-45e8b0517f4f | 1 | 2013-02-13 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| POLYETHYLENE GLYCOL-3350 AND ELECTROLYTES | POLYETHYLENE GLYCOL-3350 AND ELECTROLYTES | Novel Laboratories, Inc. | 29d821ff-389c-41fb-8a27-89bd3f022b82 | 2023-02-08 | Warnings, Adverse reactions | 8MDF5V39QO |
| f186bdc1-db6a-0fab-e053-2995a90a7c58 | a9f27b51-5710-13d4-e053-2a95a90a5435 | 2023-01-05 | Boxed warning, Warnings, Adverse reactions | a9f27b51-5710-13d4-e053-2a95a90a5435 | ||
| d167f395-73bb-da04-e053-2995a90a0385 | a839e6df-7003-8e6a-e053-2995a90a7536 | 2023-01-01 | Boxed warning, Warnings, Adverse reactions | d167f395-73bb-da04-e053-2995a90a0385 a839e6df-7003-8e6a-e053-2995a90a7536 | ||
| Omeprazole, Sodium bicarbonate | OMEPRAZOLE, SODIUM BICARBONATE | Guardian Drug Company | e5c6c2cf-fb3b-456a-a0a0-be396d6f8319 | 2022-11-08 | Warnings, Adverse reactions | 8MDF5V39QO |
| Enalapril maleate oral solution | ENALAPRIL MALEATE | Camber Pharmaceuticals, Inc. | b63bdaa6-b57b-417b-9a79-29f1fd5bbf08 | 2022-02-10 | Boxed warning, Warnings, Adverse reactions | 9O25354EPJ |
| Sodium Bicarbonate | SODIUM BICARBONATE | International Medication Systems, Limited | 77698221-a01d-4568-a7bc-d3d4e982875d | 2021-12-15 | Warnings, Adverse reactions | 8MDF5V39QO |
| 8.4% SODIUM BICARBONATE | 8.4% SODIUM BICARBONATE | HF Acquisition Co. LLC, DBA HealthFirst | 74d8bb7a-9e7a-105f-e053-2a91aa0aec92 | 2021-05-03 | Warnings, Adverse reactions | 8MDF5V39QO |
| SODIUM BICARBONATE | SODIUM BICARBONATE | Medical Purchasing Solutions, LLC | bfc9c321-665c-ca97-e053-2995a90a7954 | 2021-04-12 | Warnings, Adverse reactions | 8MDF5V39QO |
| Enalapril Maleate | ENALAPRIL MALEATE | OCEANSIDE PHARMACEUTICALS | ebd2a62d-a704-4f8a-a104-749a5296502f | 2020-12-01 | Boxed warning, Warnings, Adverse reactions | 858804 858810 858817 858813 9O25354EPJ |
| Good Sense Omeprazole and Sodium Bicarbonate | OMEPRAZOLE, SODIUM BICARBONATE | L. Perrigo Company | bcf32242-de17-4da1-b707-4ce26262eb78 | 2020-11-16 | Warnings | 8MDF5V39QO |
| Vaseretic | ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE | Bausch Health US, LLC | bf3007e2-8fcc-48de-8fd5-55e95033d62f | 2020-08-31 | Boxed warning, Warnings, Adverse reactions | 9O25354EPJ |
| Enalapril Maleate | ENALAPRIL MALEATE | Proficient Rx LP | ca1d0143-bbd3-4041-9981-eadbb8893a2b | 2020-03-01 | Boxed warning, Warnings, Adverse reactions | ANDA075657 63187-977-30 63187-977-60 63187-977-90 63187-977 858810 386e877f-e67d-4f4a-964d-ca85afc1ba32 ca1d0143-bbd3-4041-9981-eadbb8893a2b 9O25354EPJ |
| Enalapril Maleate | ENALAPRIL MALEATE | Proficient Rx LP | cc921315-8da1-487c-ba19-433470f5c8d8 | 2019-10-01 | Boxed warning, Warnings, Adverse reactions | 858817 9O25354EPJ |
| Enalapril Maleate | ENALAPRIL | Amneal Pharmaceuticals NY LLC | e81a8aca-0e7c-4a02-b596-09e4ac22c70e | 2019-03-29 | Boxed warning, Warnings, Adverse reactions | 9O25354EPJ |
| SODIUM BICARBONATE | SODIUM BICARBONATE | Aphena Pharma Solutions - Tennessee, LLC | 15605a6d-6c90-47d5-9d1f-f66a3f27d5fc | 2017-12-13 | Warnings | 8MDF5V39QO |
| Sodium Bicarbonate Antacid | SODIUM BICARBONATE | Richmond Pharmaceuticals, Inc. | e0b2f0d3-3849-4bdf-b3d4-e14e520e36ce | 2017-11-01 | Warnings | 8MDF5V39QO |
| SODIUM BICARBONATE | SODIUM BICARBONATE | Richmond Pharmaceuticals, Inc. | fa10d93d-b3ed-4675-a117-f573d9e72bca | 2017-10-30 | Warnings | 8MDF5V39QO |
| Sodium Bicarbonate | SODIUM BICARBONATE | Exela Pharma Sciences, LLC | e9698a4f-1a95-4f28-a945-e8009d1d6dd4 | 2017-09-27 | Warnings, Adverse reactions | 8MDF5V39QO |
| 0f7c3734-e05c-7082-e054-00144ff88e88 | 0f7c3734-e05b-7082-e054-00144ff88e88 | 2015-02-19 | Boxed warning, Warnings, Adverse reactions | 0f7c3734-e05c-7082-e054-00144ff88e88 0f7c3734-e05b-7082-e054-00144ff88e88 | ||
| Enalapril maleate and hydrochlorothiazide | ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE | Dr. Reddy's Laboratories Limited | ed4a55a6-cd6a-c74a-cb93-4b45641691a0 | 2010-10-04 | Boxed warning, Warnings, Adverse reactions | 9O25354EPJ |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.